Lilly, J&J boosted spending on executive security after UnitedHealth shooting
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...
Yahoo Finance1d
Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...
pharmaphorum4d
Lilly's CEO looks to M&A, but not for CAR-T or gene therapies
Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...
Lawmakers tease out pharma’s influence over RFK Jr. through probe into Mar-a-Lago meetings
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether ...
Labiotech.eu3d
Can GLP-1 agonists help treat addiction?
As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...
Fierce Pharma5d
Moderna CEO Stéphane Bancel scored pay bump in 2024 despite revenue decline and missed sales target
Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...
pharmaphorum1d
Lilly says tirzepatide supply issues are resolving
Eli Lilly has raised its revenue guidance for ... as access and supply continue to expand," said chief executive David Ricks on the company's results call. "While weekly prescription volume ...
Opinion
Observer Today4dOpinion
Economy: Having two takes on U. S. tax policy
The story of Republican tax policy in the Trump era is the contest between pro-growth ideas and anti-growth income redistribution. An example of both was on display in President Trump’s recent speech ...